A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers

Overview of attention for article published in Drug Design, Development and Therapy, April 2017

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 372 followers.

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers. https://t.co/5G0UT4kBfk

24 Feb 2018

Reply Repost Favourite

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1… https://t.co/N9TXjqskcN https://t.co/wqKhs1nPjb

10 May 2017

Reply Repost Favourite

Dove Medical Press

Article Metrics

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers

Mentioned by

Citations

Readers on